May 02, 2024
A Delaware bankruptcy judge on Thursday said she would approve the unopposed and unanimously approved Chapter 11 wind-down plans of the company previously known as Timber Pharmaceuticals Inc.
March 19, 2024
A Delaware bankruptcy judge said Tuesday she will give a debtor formerly known as Timber Pharmaceuticals Inc. permission to send its Chapter 11 plan out for a vote by the dermatology drug developer's creditors, after counsel for the company explained it had expanded the creditors' ability to opt out of the plan's claim releases.
January 22, 2024
A Delaware bankruptcy judge on Monday approved dermatology drug developer Timber Pharmaceuticals' plan for a Chapter 11 sale of its assets, with the debtor telling the court it intended to close the deal with a post-petition lender by the end of the day.
November 21, 2023
Bankrupt drug developer Timber Pharmaceuticals Inc. received interim approval Tuesday to access a portion of its $13.9 million Chapter 11 financing package after adding protections for unsecured creditors at the request of a Delaware bankruptcy judge.